Company Overview

Company name: Blueberries Medical (CNQ: BBM)
Description: Blueberries Medical Corp is a Latin American licensed producer of naturally grown premium quality cannabis with its primary operations in the Bogota Savannah of central Colombia and operations currently being established in Argentina. The Company is engaged in agriculture, genetics, extraction, medicine, pharmacology, and marketing, Blueberries is fully licensed for the cultivation, production, domestic distribution, and international export of cannabidiol (CBD) and THC (tetrahydrocannabinol)-based medical cannabis in Colombia. The company’s combination of scientific expertise, agricultural advantages, and distribution arrangements have positioned to become an international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.
Year founded: 2018
Parent company:
Industry: Materials and Resources | Group: | Code:
Website: www.blueberriesmed.com
Employees: 40
City: Bogot√°
State:
Country: Colombia
Region:

Financial Highlights

Start up capital raised (USD Million): 10.13
Business status: Generating Revenue/Not Profitable
Ownership: Publicly Held
Exchange: CNQ
Ticker: BBM
Revenue (USD Million): 0.01
Gross profit (USD Million):
Net income (USD Million) -4.64
Enterprise value: 5.25
Earnings before interest, tax, depreciation and amortization (EBITDA): -4.19
Fiscal period: TTM 2Q2020
Financing Status:
Number of active investors:
Profile last updated: 10/05/2020
Last known valuation:
Last known valuation date: